Meridian Bioscience Furthers Push into Molecular Biology with Bioline Buy | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Meridian Bioscience today said that it has acquired Bioline, a manufacturer and distributor of molecular biology reagents, for $23.3 million in cash on hand.

The acquisition pushes the Cincinnati-based diagnostics firm further into the molecular biology research products and molecular diagnostics fields. It also will provide products to complement the portfolio of its life science business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.